Biomarkers for Allergen Immunotherapy: A "Panoromic" View.

Biomarkers for Allergen Immunotherapy: A "Panoromic" View.

Immunol Allergy Clin North Am. 2016 Feb;36(1):161-79

Authors: Moingeon P

Abstract
Biomarkers (BMKs) are biological parameters that can be measured to predict or monitor disease severity or treatment efficacy. The induction of regulatory dendritic cells (DCs) concomitantly with a downregulation of proallergic DC2s (ie, DCs supporting the differentiation of T-helper lymphocyte type 2 cells) in the blood of patients allergic to grass pollen has been correlated with the early onset of allergen immunotherapy efficacy. The combined use of omics technologies to compare biological samples from clinical responders and nonresponders is being implemented in the context of nonhypothesis-driven approaches. Such comprehensive "panoromic" strategies help identify completely novel candidate BMKs, to be subsequently validated as companion diagnostics in large-scale clinical trials.

PMID: 26617233 [PubMed - in process]

from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/1lulUdv
via IFTTT